Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia

1. Agarwal, A.
2. MacKenzie, R.J.
3. Pippa, R.
4. Eide, C.A.
5. Oddo, J.
6. Tyner, J.W.
7. Sears, R.
8. Vitek, M.P.
9. Odero, M.D.
10. Christensen, D.J.
11. Druker, B.J.